DNA vaccines encoding heat shock proteins

Details DNA vaccines encoding heat shock proteins DNA vaccines encoding heat shock proteins

2009-03-02

2011-11-15

Long, Scott (Department: 1633)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C424S450000, C424S093210

Reexamination Certificate

active

08058254

ABSTRACT:
The present invention is related to a method of treating a T cell-mediated inflammatory autoimmune disease by administering to an individual in need thereof an immunogenic composition comprising a recombinant construct of a nucleic acid sequence encoding heat shock protein 60 (HSP60), or an active fragment thereof, wherein the nucleic acid sequence is operatively linked to one or more transcription control sequences, and wherein the disease is other than insulin dependent diabetes mellitus (IDDM), thereby treating the disease.

REFERENCES:
patent: 5993803 (1999-11-01), Cohen et al.
patent: 6007821 (1999-12-01), Srivastava et al.
patent: 6316420 (2001-11-01), Karin et al.
patent: 6884785 (2005-04-01), Von Herrath
patent: 2001/0031264 (2001-10-01), Segal
patent: 2002/0150586 (2002-10-01), Naparstek et al.
patent: 2003/0171280 (2003-09-01), Soderstrom
patent: 2003/0190323 (2003-10-01), Cohen et al.
patent: 2006/0089302 (2006-04-01), Abulafia-Lapid et al.
patent: 0 262 710 (1988-04-01), None
patent: 0 322 990 (1989-07-01), None
patent: WO 92/04049 (1992-03-01), None
patent: WO 97/01959 (1997-01-01), None
patent: WO 97/02016 (1997-01-01), None
patent: WO 00/27870 (2000-05-01), None
patent: WO 01/16174 (2001-03-01), None
patent: WO 01/57056 (2001-09-01), None
patent: WO 02/16549 (2002-02-01), None
patent: WO 03/026579 (2003-04-01), None
patent: WO 2005/048914 (2005-06-01), None
Wendling et al. (Journal of Immunology. 2000; 164: 2711-2717).
Corr et al. (Journal of Immunology. 1999; 163: 4721-4727).
Lanza et al. (Surgery. Jan. 1997; 121(1): 1-9).
Benhamou et al. (Diabetes & Metabolism. 1998; 24: 215-224).
Bellman et al. (FEBS Letters. 1996; 391: 185-188).
Van Eden et al. (Immunology Today. 1998. 19(7):303-307).
Prakken et al. (Current Rheumatology Reports. 2002; 4: 466-473).
W. van Eden et al., “Cloning of the Mycobacterial Epitope Recognized by T Lymphocytes in Adjuvant Arthritis”, Nature, vol. 331, No. 6152, pp. 171-173 (1988).
W. van Eden et al., “Arthritis Induced by a T-Lymphocyte Clone That Responds toMycobacterium tuberculosisand to Cartilage Proteoglycans”, Proc. Natl. Acad Sci U S A, vol. 82, pp. 5117-5120 (1985).
J. Holoshitz, et al., Arthritis Induced in Rats by Cloned T Lymphocytes Responsive to Mycobacteria But Not to Collage Type II, J. Chin Invest., vol. 73, pp. 211-215 (1984).
J. Holoshitz, et al., “Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis”, Science, vol. 219, pp. 56-58 (1983).
M. E. J. Billingham, et al., “A Mycobacterial 65-kD Heat Shock Protein Induces Antigen-Specific Suppression of Adjuvant Arthritis, But Is Not Itself Arthritogenic”, J. Exp. Med., vol. 171, pp. 334-339 (1990).
E. Hogervorst et al., “Modulation of Experimental Autoimmunity: Treatment of Adjuvant Arthritis by Immunization With a Recombinant Vaccinia Virus”. Infection and Immunity, vol. 59, No. 6, pp. 2029-2035 (1991).
S. Ragno, et al., “Protection of Rats From Adjuvant Arthritis by Immunization With Naked DNA Encoding for Mycobacterial Heat Shock Protein 65”. Arthritis Rheumatism, vol. 40, No. 2, pp. 277-283 (1997).
K. D. Moudgil,. “Diversification of T Cell Responses to Carboxy-Terminal Determinants Within the 65-kD Heat-Shock Protein Is Involved in Regulation of Autoimmune Arthritis”,. J Exp Med., vol. 185, No. 7, pp. 1307-1316 (1997).
S. M. Anderton et al., “Activation of T Cells Recognizing Self 60-kD Heat-Shock Protein Can Protect Against Experimental Arthritis”, J Exp Med., vol. 181, pp. 943-952 (1995).
X. D Yang, et al.,. “Prevention of Adjuvant Arthritis in Rats by a Nonapeptide From the 65-kD Mycobacterial Heat Shock Protein: Specificity and Mechanism”, . Clin. Exp Immunol., vol. 87, pp. 99-104 (1992).
W. van Eden et al.,. “Arthritis Protective Regulatory Potential of Self-Heat Shock Protein Cross-Reactive T Cells”, . Cell Stress & Chaperones, vol. 5, No. 5, pp. 452-457 (2000).
J. A., Lopez-Guerrero et al., “Modulation of adjuvant arthritis in Lewis rats by recombinant vaccinia virus expressing the human 60-kilodalton heat shock protein”, . Infection and Immunity, vol. 61, No. 10, pp. 4225-4231(1993).
J. A., Lopez-Guerrero et al., “Therapeutic Effect of Recombinant Vaccinia Virus Expressing the 60-kD Heat-Shock Protein on Adjuvant Arthritis”, .Arthritis Rheumatism, vol. 37, No. 10, pp. 1462-1467 (1994).
F. J. Quintana et al.,. “Inhibition of Adjuvant Arthritis by a DNA Vaccine Encoding Human Heat Shock Protein 601”, Journal of Immunology, vol. 169, pp. 3422-3428 (2002).
S. M. Anderton et al., “Differential Mycobacterial 60-kDa Heat-Shock Protein T Cell Epitope Recognition After Adjuvant Arthritis-Inducing or Protective Immunization Protocols”, Journal of Immunology, vol. 152, pp. 3656-3664 (1994).
F. J. Quintana et al., “Vaccination With Empty Plasmid DNA or CpG Oligonucleotide Inhibits Diabetes in Nonobese Diabetic Mice. Modulation of Spontaneous 60-KDa Heat Shock Protein Autoimmunity1”, Journal of Immunology, vol. 165, pp. 6148-6155 (2000).
A. G. S. van Halteren et al., “Cross-Reactive Mycobacterial and Self hsp60 Epitope Recognition in I-AG7Expressing NOD, NOD-asp and Biozzi AB/H Mice”. Journal of Autoimmunity, vol. 18, pp. 139-147, (2002).
Giomi B. et al., “Th1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid”. J Dermatol Sci. Nov. 2002;30(2):116-28.
Phipps P.A. et al., “Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit”. Eur J Immunol. Jan. 2003;33(1):224-32.
Raz I. et al., “Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide” (DiaPep277): a randomised, double-blind, phase II trial. Lancet. Nov. 24, 2001;358(9295):1749-53.
van Tienhoven E.A. et al., “Induction of antigen specific CD4+ T cell responses by invariant chain based DNA vaccines”. Vaccine. Jan. 8, 2001;19(11-12):1515-9.
G. Kroemer et al., “Differential Involvement of Th1 and Th2 Cytokines in Autoimmune Diseases”, Autoimmunity, 1996; vol. 24, pp. 25-33.
Invitrogen pcDNA3 sequence, Jul. 1, 1995.
Srivastava et al., “Gene Vaccines”, Annals of Internal Medicine, Apr. 1, 2003; vol. 138 No. 7, 138 pp. 550-559.
Venner et al, “Nucleotide Sequences and Novel Structural Features of Human and Chinese Hamster hsp60 (Chaperonin) Gene Families” DNA Cell Biol. Oct. 1990 vol. 9 No. 8 pp. 545-552.
Van Eden et al. Do Heat Shock Proteins Control the Balance of T-Cell Regulation in Inflammatory Diseases?, Immunology Today, Jul. 1998; vol. 19 No. 7, pp. 303-307.
Boog et al. “Two Monoclonal Antibodies Generated Against Human hsp60 Show Reactivity With Synovial Membranes of Patients With Juvenile Chronic Arthritis”, J. Exp. Med. 1992, vol. 175; pp. 1805-1810.
Anderton et al., “Activation of T Cells Recognizing Self 60-kD Heat Shock Protein Can Protect Against Experimental Arthritis” J. Exp Med. Mar. 1, 1995; vol. 181; pp. 943-952.
Abulafia-Lapid R. et al., “T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides”. J Autoimmun. Mar. 1999;12(2):121-9.
Nemoto T. et al., “Domain structures and immunogenic regions of the 90-kDa heat-shock protein (HSP90). Probing with a library of anti-HSP90 monoclonal antibodies and limited proteolysis”. J Biol Chem. Oct. 17, 1997;272(42):26179-87.
Chernajovsky, Y. et al., (1997) Pathogenic lymphoid cells engineered to express TGF beta1 ameliorate disease in a collagen-induced arthritis, Gene Therapy, vol. 4(6):pp. 553-559.
Cohen, Irun R. (2000) Discrimination and dialogue in the immune system, Seminars in Immunology, vol. 12(3):pp. 215-219.
Denis, Olivier et al., (1998) Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+and CD8+T-cell epitopic repertoire broader than that stimulated byMycobacterium tub

Affiliated with

Also associated with

Rating

DNA vaccines encoding heat shock proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DNA vaccines encoding heat shock proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA vaccines encoding heat shock proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4264632